Controlled-release tablet for treating epidemic hemorrhagic fever and preparation method thereof

A technology of epidemic hemorrhagic fever and sustained-release tablets, which can be applied to medical preparations containing active ingredients, pharmaceutical formulations, medical raw materials derived from fish feed, etc. , Western medicine side effects and other problems

Inactive Publication Date: 2016-03-02
徐淑美
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The clinical treatment of this disease is mainly based on western medicine, but the side effects of western medicine are large, many patients have adverse reactions to western medicine, and the therapeutic effect on epidemic hemorrhagic fever is not significant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Controlled-release tablet for treating epidemic hemorrhagic fever and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] A slow-release tablet for treating epidemic hemorrhagic fever, the slow-release tablet is composed of the following raw materials in parts by weight: 20 parts of burdock fruit, 10 parts of peppermint, 20 parts of cicada slough, 20 parts of cohosh, 20 parts of Peucedanum, 10 parts of balsam pear, 20 parts of bitter melon, 10 parts of horsetail, 8 parts of gardenia, 8 parts of heartwort, 4 parts of talcum powder, 5 parts of akebia, 6 parts of dandelion, 10 parts of white hyssop, 10 parts of sturgeon, worm 6 parts of Mormon Grass, 10 parts of Zhishouwu, 10 parts of Polygonatum, 5 parts of Chishizhi, 8 parts of Cnidium, 5 parts of Cornus officinalis, 10 parts of Red Ginseng, 10 parts of Zhigancao, 5 parts of lactose, 3 parts of pregelatinized starch, Potassium alginate 3 parts, carnauba wax 4 parts, chitosan 1 part, magnesium lauryl sulfate 0.5 part, polysorbate 0.5 part.

[0055] The preparation method of the sustained-release tablet for the treatment of epidemic hemorrhag...

Embodiment 2

[0065] A slow-release tablet for treating epidemic hemorrhagic fever, the slow-release tablet is composed of the following raw materials in parts by weight: 25 parts of burdock fruit, 15 parts of peppermint, 30 parts of cicada slough, 25 parts of cohosh, 25 parts of Peucedanum, 18 parts of balsam pear, 25 parts of bitter melon, 15 parts of horsetail, 12 parts of gardenia, 12 parts of heartwort, 8 parts of talcum powder, 10 parts of akebia, 11 parts of dandelion, 15 parts of white hyssop, 15 parts of sturgeon, insect 8 parts of Mormon Grass, 15 parts of Zhishouwu, 15 parts of Polygonatum, 8 parts of Chishi Zhi, 10 parts of Cnidium, 7 parts of Cornus officinalis, 13 parts of Red Ginseng, 15 parts of Zhigancao, 8 parts of lactose, 4 parts of pregelatinized starch, Potassium alginate 4 parts, carnauba wax 5 parts, chitosan 2 parts, magnesium lauryl sulfate 0.75 parts, polysorbate 0.75 parts.

[0066] The preparation method of this embodiment is the same as that of Example 1.

Embodiment 3

[0068] A slow-release tablet for treating epidemic hemorrhagic fever, the slow-release tablet is composed of the following raw materials in parts by weight: 30 parts of burdock fruit, 20 parts of peppermint, 40 parts of cicada slough, 30 parts of cohosh, 30 parts of Peucedanum, 25 parts of fenugreek, 30 parts of bitter gourd, 20 parts of horsetail, 16 parts of gardenia, 16 parts of heartwort, 12 parts of talcum powder, 15 parts of akebia, 16 parts of dandelion, 20 parts of white achyranthes, 20 parts of sturgeon, worm 10 parts of Mormon Grass, 20 parts of Shouwu, 20 parts of Polygonatum, 10 parts of Chishi Zhi, 12 parts of Cnidium, 10 parts of Cornus officinalis, 16 parts of Red Ginseng, 20 parts of Zhigancao, 10 parts of lactose, 5 parts of pregelatinized starch, Potassium alginate 5 parts, carnauba wax 6 parts, chitosan 3 parts, magnesium lauryl sulfate 1 part, polysorbate 1 part.

[0069] The preparation method of this embodiment is the same as that of Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a controlled-release tablet for treating epidemic hemorrhagic fever. The controlled-release tablet is composed of burdock, mint, cicada slough, Rhizoma cimicifugae, Radix peucedani, Lemna minor, Momordica charantia, Equisetum hiemale, Fructus gardeniae, Canscora lucidissima, talcum powder, Caulis akebiae, dandelion, cucubalus root, sturgeon, Chongshencao, Radix polygonum multiflorum preparata, Rhizoma polygonati, Halloystium rubrum, Fructus cnidii, Fructus corni, Radix ginseng rubra, prepared licorice root, lactose, pregelatinized starch, potassium alginate, Carnauba wax, chitosan, lauryl magnesium sulfate and polysorbate. The controlled-release tablet has exact treatment effect on epidemic hemorrhagic fever and is highly symptom-targeted and disease-oriented. Active ingredients in the controlled-release tablet can be absorbed quickly, the controlled-release tablet can relieve exterior syndrome with drugs pungent in flavor and cool in property, clear heat for detoxification, induce diuresis and relieve stranguria, warm yang and improve dehydration, can quickly and effectively treat the epidemic hemorrhagic fever and is low in administration frequency and high in patient compliance.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a slow-release tablet for treating epidemic hemorrhagic fever and a preparation method thereof. Background technique [0002] Hemorrhagic fever, also known as hemorrhagic fever with renal syndrome, is an important infectious disease that endangers human health. It is caused by epidemic hemorrhagic fever virus (Hantavirus) and is a natural source of epidemics with rodents as the main source of infection. disease. The main clinical manifestations are fever, hemorrhage, hyperemia, hypotensive shock and kidney damage. Mainly distributed in Eurasia, it is an important infectious disease that endangers human health. Since the mid-1980s in my country, the annual incidence of this disease has exceeded 100,000. The disease has a wide range of epidemics, high fatality rate, and great harm. It is one of the infectious diseases that the country focuses on...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8969A61K9/22A61K47/44A61P31/14A61K35/64A61K33/12A61K35/60A61K33/26
CPCA61K36/28A61K9/2013A61K9/2018A61K9/205A61K9/2059A61K9/2068A61K33/12A61K33/26A61K35/60A61K35/63A61K36/11A61K36/185A61K36/23A61K36/234A61K36/258A61K36/288A61K36/36A61K36/40A61K36/42A61K36/484A61K36/51A61K36/534A61K36/704A61K36/71A61K36/744A61K36/88A61K36/8969A61K2236/15A61K2236/331A61K2236/39A61K2236/51A61K2300/00
Inventor 徐淑美
Owner 徐淑美
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap